Skip to main content
Smart Investors Daily
MM

NASDAQ · MMSI

Merit Medical Systems, Inc.

Healthcare · Medical - Instruments & Supplies

$84.41

Down-$1.52 (-1.77%)

Updated Nov 20, 2026, 2:01 AM

SID Score

3.7/10

Composite research score

Smart Money

58/100

Neutral

Market cap
5.13B
P/E ratio
43.29
Dividend yield
0.00%
52-week range
$59.74 – $94.85
Volume
579.43K
Avg. volume
651.31K

Price performance · MMSI

MMSI price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Nov 19, 2026

MMSI closed at $84.41 after 21 trading sessions, down 10.14% for the selected period.

Last close
$84.41
Period change
-10.14%
Period low
$84.16
Period high
$94.20
Daily close
View OHLC price history
MMSI OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 19, 2026$85.18$86.915$84.06$84.41579.43K
Nov 18, 2026$84.36$86.37$83.89$85.93493.82K
Nov 17, 2026$85.69$86.31$84.145$84.49630.48K
Nov 16, 2026$86.90$87.565$85.89$86.35525.39K
Nov 13, 2026$86.95$87.365$85.97$86.63421.76K
Nov 12, 2026$88.28$89.53$85.57$86.69540.03K
Nov 11, 2026$87.67$88.38$86.3555$88.07441.98K
Nov 10, 2026$87.97$89.01$87.21$87.81480.46K
Nov 9, 2026$88.00$89.30$87.44$88.42507.1K
Nov 6, 2026$88.33$88.96$87.045$87.23354.02K
Nov 5, 2026$91.18$92.92$88.795$89.62940.19K
Nov 4, 2026$87.03$91.40$85.71$90.631.39M
Nov 3, 2026$84.04$85.055$83.56$84.16851.04K
Nov 2, 2026$86.26$86.34$83.72$84.311.2M
Oct 30, 2026$91.00$92.445$84.00$86.241.8M
Oct 29, 2026$93.09$93.78$91.30$93.39979.23K
Oct 28, 2026$92.71$94.12$92.0103$92.21543.39K
Oct 27, 2026$94.20$94.45$93.12$93.53731.98K
Oct 26, 2026$93.42$94.85$93.30$94.201M
Oct 23, 2026$93.57$93.87$92.77$93.30750.56K
Oct 22, 2026$91.40$94.16$89.1286$93.94655.04K

Latest MMSI news

The latest Smart Investors Daily articles mentioning MMSI.

MMSI research

Overview

Company profile and research snapshot.

Company profile

Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$104.33
Implied upside
—
Analysts
—
MMSI recent ratings
DateFirmRatingTarget
Nov 12, 2026Freedom Capital MarketsHold—
Oct 30, 2026NeedhamBuy—
Oct 30, 2026BTIGBuy—
Oct 30, 2026JP MorganOverweight—
Oct 30, 2026Canaccord GenuityBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Nov 5, 2026

Merit Medical Presents Real-World Data from the AVF Cohort of the WRAP Global Registry

The 6-month target lesion primary patency (TLPP)1 and access circuit primary patency (ACPP)2 for patients in the arteriovenous fistula (AVF) cohort were 92.7% and 76.7%, respectivelyThe real-world patency results observed in the WRAP Global Registry are higher than the patency results from the WRAPSODY Arteriovenous Access Efficacy (WAVE) pivotal trial, validating the already favorable performance of the device SOUTH JORDAN, Utah, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NA

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.